Related Experiment Video

Updated: Oct 16, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Gene vectors for cytokine expression in vivo

M M Hitt1, J Gauldie

  • 1McMaster University, Department of Pathology and Molecular Medicine, HSC-4H30C, Hamilton, Ontario, L8N 3Z5, Canada. hittma@mcmaster.ca

Current Pharmaceutical Design
|May 2, 2000
PubMed

Insights

Gene therapy vectors deliver cytokines in vivo for treating diseases like cancer and immune disorders. Advances in viral and nonviral vectors are reviewed for effective cytokine gene delivery and therapeutic applications.

Area of Science:

  • Immunology
  • Gene Therapy
  • Molecular Biology

Background:

  • Cytokines are crucial for immune responses, but their instability limits therapeutic use.
  • Gene therapy offers a solution by enabling in vivo cytokine expression.
  • Developing effective delivery systems is key for treating immune and inflammatory diseases and cancer.

Purpose of the Study:

  • To review recent advances in cytokine-encoding gene therapy vectors.
  • To compare the properties of various vector systems for cytokine gene delivery.
  • To discuss the applications of these vectors in research and therapy.

Main Methods:

  • Review of recent developments in adenovirus, adeno-associated virus, poxvirus, retrovirus, lentivirus, and nonviral vectors.
  • Comparative analysis of vector system properties relevant to in vivo cytokine gene delivery.
  • Summary of implemented strategies for immune response analysis and disease therapy.

Main Results:

  • Numerous gene therapy vectors have been developed for in vivo cytokine expression.
  • Adenovirus, AAV, poxvirus, retrovirus, lentivirus, and nonviral vectors show promise.
  • Vector properties vary, influencing their suitability for specific gene delivery applications.

Conclusions:

  • Cytokine gene therapy vectors are essential tools for understanding and treating immune-related diseases and cancer.
  • Ongoing advancements in vector design enhance their therapeutic potential.
  • Effective in vivo cytokine delivery via gene therapy holds significant promise for diverse clinical applications.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts11:11

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts

Published on: December 17, 2016

Related Concept Videos

Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...